Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients.
兩名小兒糖原貯積症1b患者接受 empagliflozin 治療後的良好結果。
Front Pediatr 2022-12-21
Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders.
使用 empagliflozin 來治療糖原貯積症 Ib 型的病因和有效治療的最新認識:從性糖尿病中獲得的新見解對其他代謝性疾病可能產生的影響。
Front Endocrinol (Lausanne) 2023-05-11
Treatment of the Neutropenia Associated with GSD1b and G6PC3 Deficiency with SGLT2 Inhibitors.
治療與GSD1b和G6PC3缺乏相關的中性粒細胞減少症:SGLT2抑制劑的應用
Diagnostics (Basel) 2023-05-30
[Short-term efficacy of empagliflozin in children with glycogen storage disease type Ⅰb].
《empagliflozin在Ⅰb型糖原貯積病兒童中的短期療效》
Zhonghua Er Ke Za Zhi 2023-06-15
Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation.
評估土耳其一組表現不同的小兒糖原貯存病1b患者的診斷、治療和追蹤,以及一種新突變。
J Pediatr Endocrinol Metab 2023-11-14
Clinical Remission of Severe Crohn's Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b.
嚴重克隆氏病在一名糖原貯積病1b型小兒患者中,單獨使用 empagliflozin 實現臨床緩解。
JPGN Rep 2023-12-02
Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study.
糖原貯積症Ib型患者的臨床範疇、12年追蹤及SGLT2抑制劑治療經驗:單中心回顧性研究。
Orphanet J Rare Dis 2024-04-15
[Investigation on the treatment of empagliflozin in glycogen storage disease type Ib].
[探討 empagliflozin 在肝醣儲存病 Ib 型治療中的作用]
Zhonghua Er Ke Za Zhi 2024-05-19
Case report: The success of empagliflozin therapy for glycogen storage disease type 1b.
病例報告:empagliflozin治療對糖原貯積病1b型的成功。
Front Endocrinol (Lausanne) 2024-06-26